Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease

被引:34
|
作者
Lakatos, Peter Laszlo [1 ]
Czegledi, Zsofia [2 ]
David, Gyula [3 ]
Kispal, Zsofia [1 ]
Kiss, Lajos S. [1 ]
Palatka, Karoly [4 ]
Kristof, Tunde [5 ]
Nagy, Ferenc [6 ]
Salamon, Agnes [7 ]
Demeter, Pal [8 ]
Miheller, Pal [1 ]
Szamosi, Tamas [2 ]
Banai, Janos [2 ]
Papp, Maria [4 ]
Bene, Laszlo [9 ]
Kovacs, Agota [9 ]
Racz, Istvan [10 ]
Lakatos, Laszlo [3 ]
机构
[1] Semmelweis Univ, Dept Med 1, H-1083 Budapest, Hungary
[2] State Hlth Ctr, Dept Gastroenterol, Budapest, Hungary
[3] Csolnoky F Cty Hosp, Dept Med 1, Veszprem, Hungary
[4] Univ Debrecen, Dept Med 2, Debrecen, Hungary
[5] Miskolc Cty Hosp, Dept Med 2, Miskolc, Hungary
[6] Univ Szeged, Dept Med 1, Szeged, Hungary
[7] Szekszard Cty Hosp, Dept Med 2, Szekszard, Hungary
[8] Janos Hosp, Dept Gastroenterol, Budapest, Hungary
[9] Peterfi Hosp, Dept Med 1, Budapest, Hungary
[10] Petz Aladar Cty & Teaching Hosp, Dept Gastroenterol, Gyor, Hungary
来源
JOURNAL OF CROHNS & COLITIS | 2010年 / 4卷 / 03期
关键词
IBD; CD; UC; Adherence; Complementary medicine; MEDICATION ADHERENCE; ULCERATIVE-COLITIS; NATIONAL-SURVEY; NONADHERENCE; AZATHIOPRINE; PREVALENCE; PREDICTORS; CARE;
D O I
10.1016/j.crohns.2009.11.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Previous studies have suggested an increasing use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD). Furthermore, a significant number of IBD patients fail to comply with treatment. The aim of our study was to evaluate the prevalence of non-adherence and the use of CAM in Hungarian patients with IBD. Methods: A total of 655 consecutive IBD patients (CD: 344, age: 38.2 [SD 12.9] years; UC: 311, age: 44.9 [15.3] years) were interviewed during the specialist visit by self-administered questionnaire including demographic and disease-related data as well as items analyzing the extent of non-adherence and CAM use. Patients taking more than 80% of each prescribed medication were classified as adherent. Results: The overall rate of self-reported non-adherence (CD: 20.9%, UC: 20.6%) and CAM (CD: 31.7%, UC: 30.9%) use did not differ between Crohn's disease (CD) and ulcerative colitis (UC). The most common causes of non-adherence were: forgetfulness (47.8%), too many/unnecessary pills (39.7%), being afraid of side effects (27.9%) and too frequent dosing. Most common forms of CAM were herbal tea (47.3%), homeopathy (14.6%), special diet (12.2%), and acupuncture (5.8%). In CD, disease duration, date of last follow-up visit, educational level and previous surgeries were predicting factors for non-adherence. Alternative medicine use was associated in both diseases with younger age, higher educational level, and immunosuppressant use. In addition, CAM use in UC was more common in females and in patients with supportive psychiatric/psychological therapy. Conclusions: Non-adherence and CAM use is common in patients with IBD. Special attention should be paid to explore the identified predictive factors during follow-up visits to improve adherence to therapy and improving patient-doctor relationship. (C) 2009 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 50 条
  • [21] Vaccination and Complementary and Alternative Medicine in Patients with Inflammatory Bowel Disease
    Kim, Sung Bae
    Park, Soo Jung
    Chung, Sook Hee
    Hahn, Kyu Yeon
    Moon, Do Chang
    Hong, Sung Pil
    Cheon, Jae Hee
    Kim, Tae Il
    Kim, Won Ho
    INTESTINAL RESEARCH, 2014, 12 (02) : 124 - 130
  • [22] Complementary and alternative medicine use by patients with inflammatory bowel disease: Are Canadian physicians failing with conventional therapy, or not?
    Bernstein, CN
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 18 (01): : 47 - 48
  • [23] Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease
    Groechenig, Hans Peter
    Waldhoer, Thomas
    Haas, Thomas
    Wenzl, Heimo
    Steiner, Pius
    Koch, Robert
    Feichtenschlager, Thomas
    Eckhardt, Gerald
    Mayer, Andreas
    Kirchgatterer, Andreas
    Ludwiczek, Othmar
    Platzer, Reingard
    Papay, Pavol
    Gartner, Johanna
    Fuchssteiner, Harry
    Miehsler, Wolfgang
    Peters, Paul-Gerhard
    Reicht, Gerhard
    Kutschera, Maximilian
    Dejaco, Clemens
    Vogelsang, Harald
    Novacek, Gottfried
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (10) : 1211 - 1219
  • [24] Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study
    Oxelmark, Lena
    Lindberg, Annelie
    Lofberg, Robert
    Sternby, Berit
    Eriksson, Anders
    Almer, Sven
    Befrits, Ragnar
    Fossum, Bjoorn
    Karlen, Per
    Brostrom, Olle
    Tysk, Curt
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (11) : 1320 - 1328
  • [25] Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease
    Markowitz, JE
    Mamula, P
    delRosario, JF
    Baldassano, RN
    Lewis, JD
    Jawad, AF
    Culton, K
    Strom, BL
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) : 599 - 605
  • [26] Use of Complementary and Alternative Medicine in Inflammatory Bowel Disease Around the World
    Zezos, Petros
    Nguyen, Geoffrey C.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (04) : 679 - +
  • [27] Patients with inflammatory bowel disease take as much complementary/alternative medicine as patients with functional bowel disease
    Kong, SC
    Pocock, CY
    Hurlstone, DP
    Bramble, MG
    McAlindon, ME
    Sanders, DS
    GUT, 2003, 52 : A67 - A67
  • [28] Complementary and alternative medicine use by patients with inflammatory bowel disease: Are Canadian physicians failing with conventional therapy, or not? Response
    Hilsden, RJ
    Verhoef, MJ
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 18 (01): : 48 - 48
  • [29] Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence?
    Cha, Jae Myung
    INTESTINAL RESEARCH, 2020, 18 (02) : 141 - 143
  • [30] The Compliant Study (Complementary and Alternative Medicine: Prevelance and Longitudinal Impact on Adherence to Conventional Therapy in Inflammatory Bowel Disease)
    Weizman, Adam V.
    Ahn, Eric
    Thanabalan, Reka
    Nguyen, Geoffrey C.
    GASTROENTEROLOGY, 2011, 140 (05) : S777 - S777